Three Percent Saline Administration During Pediatric Critical Care Transport

OBJECTIVESThe purpose of this study was to describe the administration of 3% saline (3%S) during pediatric critical care transport. METHODSA retrospective study was performed on pediatric patients who underwent critical transport to Loma Linda University Children’s Hospital from January 1, 2003, to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric emergency care 2011-12, Vol.27 (12), p.1113-1117
Hauptverfasser: Luu, Johnny L, Wendtland, Cherry L, Gross, Matthew F, Mirza, Farrukh, Zouros, Alexander, Zimmerman, Grenith J, Barcega, Besh, Abd-Allah, Shamel A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVESThe purpose of this study was to describe the administration of 3% saline (3%S) during pediatric critical care transport. METHODSA retrospective study was performed on pediatric patients who underwent critical transport to Loma Linda University Children’s Hospital from January 1, 2003, to June 30, 2007, and were given 3%S. Patients’ demographics, admission diagnosis, route and amount of 3%S administration, serum electrolytes, vital signs, radiographic data, and Glasgow Coma Scale scores were collected and analyzed. RESULTSA total of 101 children who received 3%S infusions during pediatric critical care transport were identified. Mean patient age was 5.9 years, and mean patient weight was 27.6 kg. The main indications for infusing 3%S were suspected cerebral edema (41%), intracranial bleed with edema (51%), and symptomatic hyponatremia (6%). The amount of 3%S bolus ranged from 1.2 to 24 mL/kg, with a mean of 5.4 mL/kg. Serum electrolytes before and after 3%S infusion demonstrated significant increases in sodium, chloride, and bicarbonate levels (P < 0.05). A significant reduction was also seen in serum urea nitrogen levels and anion gap. Radiographic imaging performed before 3%S infusion demonstrated findings consistent with concerns of increased intracranial pressure such as intracranial bleed and cerebral edema. The route of initial 3%S infusions was mainly through peripheral intravenous lines (96%). No complications related to the 3%S delivery such as local reactions, renal abnormalities, or central pontine myelinolysis were observed. CONCLUSIONSIt seems 3%S may be administered safely during pediatric critical transport and administration routes can include peripheral lines. With the importance of initiating therapy early to improve patient outcomes, the use of 3%S may benefit transported children with brain injury and suspected intracranial hypertension.
ISSN:0749-5161
1535-1815
DOI:10.1097/PEC.0b013e31823aff59